Author | Zoneddy Dayao, MD

Articles

HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review

April 15, 2014

This review discusses the treatment of primary, nonmetastatic HER2-positive breast cancer in the adjuvant and neoadjuvant settings-settings in which tremendous progress has been made.